TLDR Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.
The document from 1994 reviews the effectiveness of cromolyn sodium in treating asthma in children under 2 years old, with mixed results across different studies. Henry et al.'s study with 23 patients aged 4 to 23.6 months showed no significant improvement with cromolyn compared to placebo. Geller-Bernstein and Levin's study with 49 patients aged 3-24 months found cromolyn more effective in controlling wheezing in children aged 12-24 months but not in younger children. Yuksel and Greenough's study with 16 patients aged 4-31 months reported significant improvement with cromolyn, including in patients less than 12 months old. The document suggests that age may influence the response to cromolyn, with older children benefiting more, and highlights the need for more controlled trials to assess efficacy and safety, especially in infants. Cromolyn is recommended for a six-week trial in children under 2 with recurrent asthma due to the lack of other safe treatments. The document also discusses amiloride for treating lithium-induced polyuria, recommending a starting dose of 10 mg/day with close monitoring, and notes the usefulness of quantitative fluorometry and fluorescein in predicting vascular complications in transplants and assessing the viability of skin flaps, respectively.
58 citations,
October 1993 in “International Journal of Dermatology” Minoxidil helps hair growth and reduces shedding in women.
29 citations,
January 1993 in “Dermatologic Clinics” Certain medications and maintaining adequate iron levels can help manage women's hair loss.
43 citations,
November 1992 in “International Journal of Dermatology” Minoxidil 2% effectively treats female hair loss, promoting growth and density.
85 citations,
December 1990 in “Journal of Investigative Dermatology” Minoxidil promotes hair growth in women with early-stage alopecia.
33 citations,
April 1990 in “Dermatologic Clinics” Minoxidil effectively treats hair loss, with better results in women.
37 citations,
January 1987 in “Dermatology” Minoxidil stimulates hair growth by increasing hair thickness and prolonging growth phase.
666 citations,
September 1977 in “British Journal of Dermatology” Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.
60 citations,
September 2015 in “Expert Review of Clinical Immunology” Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.
9 citations,
October 2018 in “Elsevier eBooks” Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.
80 citations,
August 1991 in “The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunology” Methotrexate reduced the need for steroids in asthma patients without worsening their condition.
49 citations,
October 2014 in “International Scholarly Research Notices” Eclipta alba has many health benefits and contains compounds with potential for drug development.
22 citations,
August 2017 in “Stem cells and cloning” Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.
